In this article ASAN PD DASH HZNP MRVL ZS Follow your favorite stocksCREATE FREE ACCOUNT Zscaler rings the opening bell at the Nasdaq exchange in New York, March 16, 2018. Source: Nasdaq Check out the companies making headlines in midday trading. Zscaler – The cloud security company’s shares dipped 10.7% following its quarterly earnings report,
0 Comments
Many sectors have been damaged in the train wreck of this year’s stock market. But few have been as hard hit as the stocks of financial technology (fintech) companies. These are companies using new technologies to compete with traditional banks and other financial institutions. Think payment apps, online lenders and digital exchanges. Most fintech companies
0 Comments
In this week’s episode of let’s talk stocks, we’re going to take a look at knowledge vs. wisdom. These days, the educational system is set up to help you acquire knowledge, but it doesn’t help you attain much wisdom. Unfortunately, knowledge is not very useful without wisdom. In this video, I’ll show you the importance
0 Comments
Public Sector Pension Investment Board reduced its holdings in Huntington Bancshares Incorporated (NASDAQ:HBAN – Get Rating) by 31.5% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 138,471 shares of the bank’s stock after selling 63,808 shares during the quarter. Public Sector
0 Comments
Stocks across the board have plunged in 2022. Even the seemingly invincible tech giants, such as Netflix (NASDAQ:NFLX), have witnessed year-to-date (YTD) declines of over 50%. The crypto market has fallen too, as investors realize that a bet on crypto is essentially a bet on a high-risk asset. The insolvency of FTX drove the price
0 Comments
Investors like penny stocks because of their upside potential. Those same investors should consider seeking out the best green penny stocks in particular because a clear trend toward sustainable investing isn’t slowing: Between 2018 and 2036 ESG and sustainable investing are expected to grow by 43%.  The worldview is changing and more and more investors
0 Comments
Tracey Ryniec and David Bartosiak, Stock Strategists at Zacks Investment Research, discuss pharmaceutical giant Eli Lilly’s (LLY) recent announcement of its termination of its Phase III trial of its cardiovascular drug, Evacetrapib, after its committee reported that the drug was unlikely to meet its endpoint. Safety of the drug was not at issue. The company
0 Comments
Warning: Undefined array key 0 in /home/etfdailynews/public_html/wp-content/themes/responsalambre/functions.php on line 144 wp-content/themes/responsalambre/images/image-pending.gif&w=240&h=240&zc=2″ class=”ff-og-image-inserted”> Federal Reserve Chair Jerome Powell said on Wednesday that the central bank could slow the rapid pace of interest rate hikes at its December meeting while indicating a protracted economic adjustment to a world where borrowing costs remain high, and inflation comes down slowly. After
0 Comments